Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (90 ops.)
Latest filing published 06 Oct 2025 for PROCTER & GAMBLE Co, €52k.
Filing timeline
BuySaleR. Alexandra Keith
Insider track record
Disclosed buys
0
Disclosed sells
90
Signal history
R. Alexandra Keith: trading record in brief
R. Alexandra Keith appears at Procter & Gamble Co as CEO Beauty with 163 filings, 90 of them sales worth EUR 66.6 million in total (median EUR 256,437). There is no purchase. The three largest sales took place on August 19, 2019 (EUR 5,003,159), October 21, 2020 (EUR 3,776,103) and November 8, 2022 (EUR 3,606,988). The record closes with 5 filings at Thermo Fisher Scientific Inc., where Keith is a director, with no market trade.
Around the sales: 50 share grants, 22 option exercises and 6 filings of another kind. The year 2020 weighs 37 filings, against 8 in 2025, the last year covered. No filing falls in the last twelve months.
Keith's trades sit very close to those of Procter & Gamble colleagues, always in the same direction: 67 within 30 days of Jon R. Moeller, 54 of Ma. Fatima Francisco, 54 of Shailesh Jejurikar, 49 of Gary A. Coombe and 48 of Carolyn M. Tastad. Filings come out a median of 1 day after the trade.
Companies and markets linked to R. Alexandra Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations168 total
399 shares@ US$152.230.1% of flowCommon StockSEC:0000080424-25-000206:1
1,855 shares@ US$152.23171.5% of flowCommon StockSEC:0000080424-25-000206:0
766 shares@ US$158.160.1% of flowCommon StockSEC:0000080424-25-000139:1
10,697 shares@ US$158.1598.8% of flowCommon StockSEC:0000080424-25-000139:0
1,725 shares0Common StockSEC:0000080424-25-000129:1
24,091 shares0Common StockSEC:0000080424-25-000129:0
361 shares0Common StockSEC:0000080424-25-000089:0
565 shares0Common StockSEC:0000097745-25-000060:0
479.13 shares@ US$169.490.1% of flowCommon StockSEC:0001127602-24-025910:1
886.756 shares@ US$169.48740.8% of flowCommon StockSEC:0001127602-24-025910:0
409 shares@ US$170.000.1% of flowCommon StockSEC:0001127602-24-025874:1
1,992 shares@ US$170.001.9% of flowCommon StockSEC:0001127602-24-025874:0
1,678 shares@ US$170.990.3% of flowCommon StockSEC:0001127602-24-025230:1
345 shares@ US$170.98990.3% of flowCommon StockSEC:0001127602-24-025230:0
12,852 shares@ US$170.052.3% of flowCommon StockSEC:0001127602-24-022902:1
880 shares@ US$170.050.8% of flowCommon StockSEC:0001127602-24-022902:0
729 shares@ US$170.590.1% of flowCommon StockSEC:0001127602-24-022817:1
10,627 shares@ US$170.59499.8% of flowCommon StockSEC:0001127602-24-022817:0
1,609 shares0Common StockSEC:0001127602-24-022632:1
23,479 shares0Common StockSEC:0001127602-24-022632:0
4,163 shares@ US$171.04753.9% of flowCommon StockSEC:0001127602-24-021964:0
3,373 shares@ US$170.003.2% of flowCommon StockSEC:0001127602-24-021687:0
191 shares0Common StockSEC:0001127602-24-021652:0
339 shares0Common StockSEC:0001127602-24-016375:0
5,493.16 shares@ US$165.88095.1% of flowCommon StockSEC:0001127602-24-015559:0
25 of 168 declarations
